SANTARUS INC 3 SEC Filings

Filed On	Filing
13 Jan 2014	Form 3: Creech Timothy J, Director No securities owned
13 Jan 2014	Form 3: Bertrand William C Jr, Director No securities owned
13 Jan 2014	Form 3: Salix Pharmaceuticals Ltd, 10% owner and 2 others Holds 100 shares of Common Stock
10 Apr 2012	Form 3: Strobeck Matthew, Director Holds 57,971 shares of Common Stock
10 Apr 2012	Form 3: Della Cha Alessandro, Director Holds 66,215 shares of Common Stock
20 Jun 2011	Form 3: Wierenga Wendall, EVP, R&D No securities owned
13 Sep 2010	Form 3: Totoritis Mark, SVP, Biologics Holds 55,191 shares of Common Stock
30 Dec 2008	Form 3: Cassiopea Sa, 10% owner and 6 others Holds 6,000,000 shares of Common Stock, Par value $0.0001 per share
29 May 2007	Form 3: Bedoya-Toro Maria E, VP, Regulatory Affairs & QA No securities owned
02 Mar 2006	Form 3: Fox Carey J, VP, General Counsel Holds 4,482 shares of Common Stock
02 Mar 2006	Form 3: Ballard E David Ii, VP, Clinical Res & Med Affairs
18 Mar 2005	Form 3: Love Ted W, Director No securities owned
16 Feb 2005	Form 3: Carter Michael G, Director No securities owned
08 Feb 2005	Form 3: Step Michael D, SVP, Corporate Development No securities owned
27 Sep 2004	Form 3: Snyder Kent, Director Holds 1,000 shares of Common Stock
28 Jul 2004	Form 3: Burgess Daniel D, Director No securities owned
28 Jul 2004	Form 3: Simmons C Christine, VP, Reg Affairs & QA Holds 16,470 shares of Common Stock
31 Mar 2004	Form 3: Klausner Arthur J, Director Holds 18,570 shares of Common Stock
31 Mar 2004	Form 3: Proehl Gerald T, Director Holds 165,712 shares of Common Stock
31 Mar 2004	Form 3: Van Der Have Frederik Vincent, Director

Comments